Crosstalk of Humoral and Cell-Cell Contact-Mediated Signals in Postnatal Body Growth

Cell Reports

Volumn 2, Issue 3, 2012, Pages 652-665

  Jing, Xuefeng ^a   Miyajima, Masayasu ^a   Sawada, Takahiro ^a   Chen, Qingfa ^a   Iida, Keiji ^b   Furushima, Kenryo ^a   Arai, Daiki ^a   Chihara, Kazuo ^b   Sakaguchi, Kazushige ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; EPHRIN A4; GROWTH HORMONE; JANUS KINASE 2; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STAT5 PROTEIN; THYROXINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY GROWTH; BODY SIZE; CELL CONTACT; COMPLEX FORMATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; EPHRIN A4 GENE; GENE; GENE DOSAGE; GENE EXPRESSION; GROWTH HORMONE BLOOD LEVEL; GROWTH REGULATION; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LIVER PARENCHYMA; MOLECULAR INTERACTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTNATAL GROWTH; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SHORT STATURE; SIGNAL TRANSDUCTION; THYROXINE BLOOD LEVEL;

ANIMALS; BODY SIZE; CELL COMMUNICATION; GENE DOSAGE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; JANUS KINASE 2; MICE; MICE, MUTANT STRAINS; RECEPTOR, EPHA4; RECEPTORS, SOMATOTROPIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

MUS;

EID: 84866951641     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.08.021     Document Type: Article

References (40)

1. Amselem S., Duquesnoy P., Attree O., Novelli G., Bousnina S., Postel-Vinay M.C., Goossens M. Laron dwarfism and mutations of the growth hormone-receptor gene. N. Engl. J. Med. 1989, 321:989-995.
2. Binoux M. GH, IGFs, IGF-binding protein-3 and acid-labile subunit: what is the pecking order?. Eur. J. Endocrinol. 1997, 137:605-609.
3. Birzniece V., Sata A., Ho K.K. Growth hormone receptor modulators. Rev. Endocr. Metab. Disord. 2009, 10:145-156.
4. Cunningham B.C., Ultsch M., De Vos A.M., Mulkerrin M.G., Clauser K.R., Wells J.A. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 1991, 254:821-825.
5. Domené H.M., Bengolea S.V., Martínez A.S., Ropelato M.G., Pennisi P., Scaglia P., Heinrich J.J., Jasper H.G. Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. N. Engl. J. Med. 2004, 350:570-577.
6. Elis S., Wu Y., Courtland H.W., Cannata D., Sun H., Beth-On M., Liu C., Jasper H., Domené H., Karabatas L., et al. Unbound (bioavailable) IGF1 enhances somatic growth. Dis. Model Mech. 2011, 4:649-658.
7. Giustina A., Veldhuis J.D. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 1998, 19:717-797.
8. Godowski P.J., Leung D.W., Meacham L.R., Galgani J.P., Hellmiss R., Keret R., Rotwein P.S., Parks J.S., Laron Z., Wood W.I. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc. Natl. Acad. Sci. USA 1989, 86:8083-8087.
9. Helmbacher F., Schneider-Maunoury S., Topilko P., Tiret L., Charnay P. Targeting of the EphA4 tyrosine kinase receptor affects dorsal/ventral pathfinding of limb motor axons. Development 2000, 127:3313-3324.
10. Iida K., Del Rincon J.P., Kim D.S., Itoh E., Nass R., Coschigano K.T., Kopchick J.J., Thorner M.O. Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist. Endocrinology 2004, 145:1564-1570.
11. Kitamura T., Koshino Y., Shibata F., Oki T., Nakajima H., Nosaka T., Kumagai H. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 2003, 31:1007-1014.
12. Kofoed E.M., Hwa V., Little B., Woods K.A., Buckway C.K., Tsubaki J., Pratt K.L., Bezrodnik L., Jasper H., Tepper A., et al. Growth hormone insensitivity associated with a STAT5b mutation. N. Engl. J. Med. 2003, 349:1139-1147.
13. Kohsaka A., Laposky A.D., Ramsey K.M., Estrada C., Joshu C., Kobayashi Y., Turek F.W., Bass J. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab. 2007, 6:414-421.
14. Kullander K., Klein R. Mechanisms and functions of Eph and ephrin signalling. Nat. Rev. Mol. Cell Biol. 2002, 3:475-486.
15. Lai K.O., Chen Y., Po H.M., Lok K.C., Gong K., Ip N.Y. Identification of the Jak/Stat proteins as novel downstream targets of EphA4 signaling in muscle: implications in the regulation of acetylcholinesterase expression. J. Biol. Chem. 2004, 279:13383-13392.
16. Laron Z., Pertzelan A., Mannheimer S. Genetic pituitary dwarfism with high serum concentation of growth hormone-a new inborn error of metabolism?. Isr. J. Med. Sci. 1966, 2:152-155.
17. Lupu F., Terwilliger J.D., Lee K., Segre G.V., Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev. Biol. 2001, 229:141-162.
18. MacLeod J.N., Pampori N.A., Shapiro B.H. Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice. J. Endocrinol. 1991, 131:395-399.
19. Nabors C.J., West C.D., Mahajan D.K., Tyler F.H. Radioimmunoassay of human plasma corticosterone: method, measurement of episodic secretion and adrenal suppression and stimulation. Steroids 1974, 23:363-378.
20. Naski M.C., Colvin J.S., Coffin J.D., Ornitz D.M. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 1998, 125:4977-4988.
21. Niiori-Onishi A., Iwasaki Y., Mutsuga N., Oiso Y., Inoue K., Saito H. Molecular mechanisms of the negative effect of insulin-like growth factor-I on growth hormone gene expression in MtT/S somatotroph cells. Endocrinology 1999, 140:344-349.
22. Ornitz D.M. Regulation of chondrocyte growth and differentiation by fibroblast growth factor receptor 3. Novartis Found. Symp. 2001, 232:63-76. discussion 76-80, 272-282.
23. Pasquale E.B. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008, 133:38-52.
24. Pilecka I., Whatmore A., Hooft van Huijsduijnen R., Destenaves B., Clayton P. Growth hormone signalling: sprouting links between pathways, human genetics and therapeutic options. Trends Endocrinol. Metab. 2007, 18:12-18.
25. Piwien-Pilipuk G., Huo J.S., Schwartz J. Growth hormone signal transduction. J. Pediatr. Endocrinol. Metab. 2002, 15:771-786.
26. Rowlinson S.W., Behncken S.N., Rowland J.E., Clarkson R.W., Strasburger C.J., Wu Z., Baumbach W., Waters M.J. Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies. A specific conformational change may be required for full-length receptor signaling. J. Biol. Chem. 1998, 273:5307-5314.
27. Sawada T., Jing X., Zhang Y., Shimada E., Yokote H., Miyajima M., Sakaguchi K. Ternary complex formation of EphA4, FGFR and FRS2alpha plays an important role in the proliferation of embryonic neural stem/progenitor cells. Genes Cells 2010, 15:297-311.
28. Sjögren K., Liu J.L., Blad K., Skrtic S., Vidal O., Wallenius V., LeRoith D., Törnell J., Isaksson O.G., Jansson J.O., Ohlsson C. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. USA 1999, 96:7088-7092.
29. Stratikopoulos E., Szabolcs M., Dragatsis I., Klinakis A., Efstratiadis A. The hormonal action of IGF1 in postnatal mouse growth. Proc. Natl. Acad. Sci. USA 2008, 105:19378-19383.
30. Wagner K.U., Krempler A., Triplett A.A., Qi Y., George N.M., Zhu J., Rui H. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol. Cell. Biol. 2004, 24:5510-5520.
31. Walenkamp M.J., Wit J.M. Genetic disorders in the growth hormone - insulin-like growth factor-I axis. Horm. Res. 2006, 66:221-230.
32. Woods K. Genetic defects of the growth-hormone-IGF axis associated with growth hormone insensitivity. Endocr. Dev. 2007, 11:6-15.
33. Woods K.A., Camacho-Hübner C., Savage M.O., Clark A.J. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N. Engl. J. Med. 1996, 335:1363-1367.
34. Yakar S., Liu J.L., Stannard B., Butler A., Accili D., Sauer B., LeRoith D. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 1999, 96:7324-7329.
35. Yakar S., Bouxsein M.L., Canalis E., Sun H., Glatt V., Gundberg C., Cohen P., Hwang D., Boisclair Y., Leroith D., Rosen C.J. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. J. Endocrinol. 2006, 189:289-299.
36. Yakar S., Rosen C.J., Bouxsein M.L., Sun H., Mejia W., Kawashima Y., Wu Y., Emerton K., Williams V., Jepsen K., et al. Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism. FASEB J. 2009, 23:709-719.
37. Yokote H., Fujita K., Jing X., Sawada T., Liang S., Yao L., Yan X., Zhang Y., Schlessinger J., Sakaguchi K. Trans-activation of EphA4 and FGF receptors mediated by direct interactions between their cytoplasmic domains. Proc. Natl. Acad. Sci. USA 2005, 102:18866-18871.
38. Zhang J., Hughes S. Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J. Pathol. 2006, 208:453-461.
39. Zhang Y., Sawada T., Jing X., Yokote H., Yan X., Sakaguchi K. Regulation of ephexin1, a guanine nucleotide exchange factor of Rho family GTPases, by fibroblast growth factor receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 2007, 282:31103-31112.
40. Zhou Y., Xu B.C., Maheshwari H.G., He L., Reed M., Lozykowski M., Okada S., Cataldo L., Coschigamo K., Wagner T.E., et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl. Acad. Sci. USA 1997, 94:13215-13220.